Felipe Bedoya

2.4k total citations
14 papers, 495 citations indexed

About

Felipe Bedoya is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Felipe Bedoya has authored 14 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Felipe Bedoya's work include CAR-T cell therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (3 papers). Felipe Bedoya is often cited by papers focused on CAR-T cell therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (3 papers). Felipe Bedoya collaborates with scholars based in United States and Denmark. Felipe Bedoya's co-authors include Jonathan A. Harton, Marcela V. Maus, Matthew J. Frigault, Carl H. June, Selene Nuñez-Cruz, Saba Ghassemi, Michael C. Milone, Bruce L. Levine, Simon F. Lacey and J. Joseph Melenhorst and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Felipe Bedoya

14 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felipe Bedoya United States	8	324	248	210	120	116	14	495
Joanne A. Hammill Canada	10	387 1.2×	117 0.5×	254 1.2×	105 0.9×	109 0.9×	18	493
Degui Geng United States	9	308 1.0×	139 0.6×	321 1.5×	130 1.1×	84 0.7×	14	565
Xueqiang Zhao China	10	500 1.5×	189 0.8×	299 1.4×	171 1.4×	123 1.1×	14	667
Justin C. Boucher United States	12	398 1.2×	162 0.7×	254 1.2×	116 1.0×	131 1.1×	31	571
Nadine Mockel-Tenbrinck Germany	8	263 0.8×	135 0.5×	225 1.1×	92 0.8×	72 0.6×	11	405
Ryo Hanajiri Japan	10	452 1.4×	162 0.7×	200 1.0×	163 1.4×	170 1.5×	29	576
Chung-Hsi Wang Canada	7	568 1.8×	247 1.0×	304 1.4×	183 1.5×	165 1.4×	11	680
Mark Daris United States	10	279 0.9×	243 1.0×	125 0.6×	47 0.4×	127 1.1×	18	444
Decheng Song United States	7	468 1.4×	182 0.7×	229 1.1×	173 1.4×	146 1.3×	13	621
Thomas Shum United States	10	476 1.5×	172 0.7×	198 0.9×	161 1.3×	177 1.5×	17	612

Countries citing papers authored by Felipe Bedoya

Since Specialization

Citations

This map shows the geographic impact of Felipe Bedoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Bedoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Bedoya more than expected).

Fields of papers citing papers by Felipe Bedoya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felipe Bedoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Bedoya. The network helps show where Felipe Bedoya may publish in the future.

Co-authorship network of co-authors of Felipe Bedoya

This figure shows the co-authorship network connecting the top 25 collaborators of Felipe Bedoya. A scholar is included among the top collaborators of Felipe Bedoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe Bedoya. Felipe Bedoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schmidts, Andrea, Amanda A. Bouffard, Angela C. Boroughs, et al.. (2020). Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. Journal for ImmunoTherapy of Cancer. 8(2). e000990–e000990. 18 indexed citations

Ghassemi, Saba, Selene Nuñez-Cruz, Roddy S. O’Connor, et al.. (2018). Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells. Cancer Immunology Research. 6(9). 1100–1109. 212 indexed citations

Bedoya, Felipe, Matthew J. Frigault, & Marcela V. Maus. (2017). The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy. Molecular Therapy. 25(2). 314–320. 33 indexed citations

Ormhøj, Maria, Felipe Bedoya, Matthew J. Frigault, & Marcela V. Maus. (2017). CARs in the Lead Against Multiple Myeloma. Current Hematologic Malignancy Reports. 12(2). 119–125. 38 indexed citations

Orlando, Elena J., Rebecca Leary, Simon F. Lacey, et al.. (2017). Gene expression signatures of response to anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with CLL and ALL.. Journal of Clinical Oncology. 35(7_suppl). 137–137. 1 indexed citations

Ghassemi, Saba, Felipe Bedoya, Selene Nuñez-Cruz, et al.. (2016). Shortened T cell culture with IL-7 and IL-15 provides the most potent chimeric antigen receptor (CAR)-modified T cells for adoptive immunotherapy.. The Journal of Immunology. 196(1_Supplement). 214.23–214.23. 5 indexed citations

Jesuraj, Nithya, Felipe Bedoya, Steven B. Wells, et al.. (2016). A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers. Blood. 128(22). 3368–3368. 3 indexed citations

Ghassemi, Saba, Felipe Bedoya, Selene Nuñez-Cruz, et al.. (2016). 203. Shortened T Cell Culture with IL-7 and IL-15 Provides the Most Potent Chimeric Antigen Receptor (CAR)-Modified T Cells for Adoptive Immunotherapy. Molecular Therapy. 24. S79–S79. 11 indexed citations

Fraietta, Joseph A., Simon F. Lacey, Nicholas S. Wilcox, et al.. (2016). Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia. Blood. 128(22). 57–57. 15 indexed citations

10.

Ghassemi, Saba, John Scholler, Selene Nuñez-Cruz, et al.. (2016). Minimally Ex Vivo Manipulated Gene-Modified T Cells Display Enhanced Tumor Control. Blood. 128(22). 4549–4549. 3 indexed citations

11.

Weissler, Katherine A., Elizabeth Kropf, Felipe Bedoya, et al.. (2015). Distinct Modes of Antigen Presentation Promote the Formation, Differentiation, and Activity of Foxp3+ Regulatory T Cells In Vivo. The Journal of Immunology. 194(8). 3784–3797. 6 indexed citations

12.

Bedoya, Felipe, Guang‐Shing Cheng, Katherine A. Weissler, et al.. (2013). Viral Antigen Induces Differentiation of Foxp3+ Natural Regulatory T Cells in Influenza Virus–Infected Mice. The Journal of Immunology. 190(12). 6115–6125. 59 indexed citations

13.

Bedoya, Felipe, Maria M. Medveczky, Troy C. Lund, et al.. (2009). Identification of mitochondrial genome concatemers in AIDS-associated lymphomas and lymphoid cell lines. Leukemia Research. 33(11). 1499–1504. 2 indexed citations

14.

Bedoya, Felipe, et al.. (2007). Pyrin-Only Protein 2 Modulates NF-κB and Disrupts ASC:CLR Interactions. The Journal of Immunology. 178(6). 3837–3845. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact